Literature DB >> 9669271

Resolution of cardiomyopathy after ablation of atrial flutter.

J A Luchsinger1, J S Steinberg.   

Abstract

OBJECTIVES: We sought to serially assess left ventricular (LV) function before and after catheter ablation of atrial flutter (AFI).
BACKGROUND: The relation of tachycardia-induced cardiomyopathy to AFI and its response to direct catheter ablation are unknown.
METHODS: LV function was assessed in a series of 59 consecutive patients with successful radiofrequency ablation (RFA) of AFI before and after the procedure. Eleven patients had dilated cardiomyopathy (LV ejection fraction [LVEF] <50%) and congestive heart failure (CHF) symptoms and are the subject of this report. LV function was assessed by LVEF on two-dimensional echocardiography and functional status by New York Heart Association (NYHA) CHF classification.
RESULTS: Patients were 59 +/- 8 years old, and were all male. Five patients had a preablation diagnosis of idiopathic cardiomyopathy. The preablation LVEF was 30.9 +/- 11.0% and improved to 41.3 +/- 16% (p = 0.005) when measured 7 months after successful ablation. NYHA CHF class improved from 2.6 +/- 0.5 to 1.6 +/- 0.9 (p = 0.002). Six (55%) of 11 patients had normalization of the LVEF, with complete resolution of CHF symptoms. A lower preablation LVEF and functional class predicted nonresolution of dilated cardiomyopathy (p = 0.002 and 0.001, respectively).
CONCLUSIONS: Restoration of normal sinus rhythm by RFA in patients with chronic AFI and cardiomyopathy substantially improved LV function. Resolution of dilated cardiomyopathy occurred in the majority of patients. Tachycardia-induced cardiomyopathy may be a more common mechanism of LV dysfunction in patients with AFI than expected, and aggressive treatment of this arrhythmia should be considered.

Entities:  

Mesh:

Year:  1998        PMID: 9669271     DOI: 10.1016/s0735-1097(98)00183-1

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  21 in total

1.  Atrial Flutter.

Authors: 
Journal:  Curr Treat Options Cardiovasc Med       Date:  1999-08

2.  Resolution of tachycardia-induced cardiomyopathy following ablation of verapamil-sensitive idiopathic left ventricular tachycardia.

Authors:  A Arya; M Haghjoo; P Davari; M A Sadr-Ameli
Journal:  Pediatr Cardiol       Date:  2006 Jan-Feb       Impact factor: 1.655

3.  Frequency and predictors of tachycardia-induced cardiomyopathy in patients with persistent atrial flutter.

Authors:  Stephen Pizzale; Robert Lemery; Martin S Green; Michael H Gollob; Anthony S L Tang; David H Birnie
Journal:  Can J Cardiol       Date:  2009-08       Impact factor: 5.223

Review 4.  Rate Control in Atrial Fibrillation: Avoiding Morbidity.

Authors:  Thomas D Callahan
Journal:  J Atr Fibrillation       Date:  2012-12-16

5.  Atrial Flutter, Typical and Atypical: A Review.

Authors:  Francisco G Cosío
Journal:  Arrhythm Electrophysiol Rev       Date:  2017-06

Review 6.  Atrial Fibrillation and Heart Failure: A Review of the Intersection of Two Cardiac Epidemics.

Authors:  Kay Lee Park; Elad Anter
Journal:  J Atr Fibrillation       Date:  2013-06-30

7.  Reversal of cardiomyopathy in patients with congestive heart failure secondary to tachycardia.

Authors:  Zhao Donghua; Peng Jian; Xiao Zhongbo; Zhang Feifei; Peng Xinhui; Yang Hao; Liu Fuqiang; Li Yan; Xie Yong; Huang Xinfu; Meng Surong; Wu Muli; Xu Dingli
Journal:  J Interv Card Electrophysiol       Date:  2012-10-23       Impact factor: 1.900

8.  Canadian Cardiovascular Society Consensus Conference guidelines on heart failure--2008 update: best practices for the transition of care of heart failure patients, and the recognition, investigation and treatment of cardiomyopathies.

Authors:  J Malcom; O Arnold; Jonathan G Howlett; Anique Ducharme; Justin A Ezekowitz; Martin J Gardner; Nadia Giannetti; Haissam Haddad; George A Heckman; Debra Isaac; Philip Jong; Peter Liu; Elizabeth Mann; Robert S McKelvie; Gordon W Moe; Anna M Svendsen; Ross T Tsuyuki; Kelly O'Halloran; Heather J Ross; Errol J Sequeira; Michel White
Journal:  Can J Cardiol       Date:  2008-01       Impact factor: 5.223

Review 9.  Tachycardia-mediated cardiomyopathy: recognition and management.

Authors:  Rakesh Gopinathannair; Renee Sullivan; Brian Olshansky
Journal:  Curr Heart Fail Rep       Date:  2009-12

10.  Ventricular dysfunction: tachycardia induced cardiomyopathy.

Authors:  V Ramesh Iyer
Journal:  Indian Pacing Electrophysiol J       Date:  2008-05-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.